Subtype
Pancreatic Intraductal Papillary Mucinous Neoplasm
CI-CAN-00003571Explore in graph →
Non-malignant7 active trials
Loading cancer entity…
Subtype
CI-CAN-00003571Explore in graph →
Clinical trials
41 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02070705 | DCE MRI in Patients With Pancreatic Cancer | terminated | N/A | 77 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT02494388 | Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions(CINE-Cyst) | terminated | — | 10 | University of Medicine and Pharmacy CraiovaOTHER | 4 | Jan 17, 2018 | clinicaltrials |
| NCT00482625 | Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00621556 | Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas | terminated | Phase 1 | 2 | Massachusetts General HospitalOTHER | 1 | Jan 29, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jul 31, 2025source: clinicaltrials